BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $164 | $117 | $107 | $107 |
| - Cash | $11 | $4 | $3 | $2 |
| + Debt | $20 | $21 | $19 | $14 |
| Enterprise Value | $173 | $134 | $122 | $119 |
| Revenue | $9 | $9 | $8 | $7 |
| % Growth | 6.5% | 8.3% | 8% | – |
| Gross Profit | $6 | $5 | $5 | $4 |
| % Margin | 61.4% | 59.7% | 58.5% | 56.7% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -5.9% | -16.5% | -16.8% | -18.5% |
| Net Income | -$3 | -$4 | -$2 | -$3 |
| % Margin | -27.7% | -47.9% | -29.7% | -40.6% |
| EPS Diluted | -0.14 | -0.24 | -0.13 | -0.17 |
| % Growth | 41.7% | -84.6% | 23.5% | – |
| Operating Cash Flow | -$2 | -$2 | -$1 | -$3 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$3 | -$2 | -$2 | -$3 |